⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL768643 | 0.63 | — | — | |
| SCHEMBL168279 | 0.63 | — | — | |
| SCHEMBL443741 | 0.58 | — | — | |
| SCHEMBL7755115 | 0.58 | — | — | |
| Formaldehyde SCHEMBL359599 | 0.53 | — | — | |
| Formaldehyde SCHEMBL15643109 | 0.53 | — | — | |
| Formaldehyde SCHEMBL1460345 | 0.47 | — | — | |
| SCHEMBL809291 | 0.47 | — | — | |
| SCHEMBL821396 | 0.47 | — | — | |
| Formaldehyde SCHEMBL11234651 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117645965-B | Lactobacillus casei rhamnosus with intestinal indole degrading and chronic renal failure relieving functions | 青岛蔚蓝生物集团有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117645965-A | Lactobacillus casei rhamnosus with intestinal indole degrading and chronic renal failure relieving functions | 潍坊康地恩生物科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| EP-3988521-A1 | CELLULAR SENESCENCE-ACTIVATING COMPOUNDS | Universidad Nacional Autónoma De México (MX) | 2022-04-27 | — | — | EP | disclosed |
| EP-2892525-B1 | METHODS OF TREATING MUSCULAR DYSTROPHY | UNIV NEVADA RENO (US) | 2018-06-13 | — | — | EP | disclosed |
| US-20170314874-A1 | WICKLESS CAPILLARY DRIVEN CONSTRAINED VAPOR BUBBLE HEAT PIPES FOR APPLICATION IN RACK SERVERS | INTEL CORPORATION (US) | 2017-11-02 | — | — | US | disclosed |
| US-9662367-B2 | Adaptogenic compositions and method for production thereof | RUBIKON LTD. (BY) | 2017-05-30 | — | — | US | disclosed |
| WO-2016010950-A1 | SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-01-21 | — | — | WO | disclosed |
| WO-2015154169-A1 | BINDING FUNCTION3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2015-10-15 | — | — | WO | disclosed |
| US-20150108465-A1 | Electro-Optical Device | SEMICONDUCTOR ENERGY LAB (JP) | 2015-04-23 | — | — | US | disclosed |
| US-8861257-B2 | Nonvolatile memory element, manufacturing method thereof, nonvolatile memory device, and design support method for nonvolatile memory element | PANASONIC CORPORATION (JP) | 2014-10-14 | — | — | US | disclosed |
| EP-2607437-B1 | Siloxane nitrones and their application | EVONIK INDUSTRIES AG (DE) | 2014-09-03 | — | — | EP | disclosed |
| EP-2501711-B1 | Compounds and methods for purifying peptides produced by solid phase peptide synthesis | CENTRE NAT RECH SCIENT (FR) | 2014-01-08 | — | — | EP | disclosed |
| WO-2013045280-A1 | DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-04-04 | — | — | WO | disclosed |
| WO-2012168226-A1 | DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-12-13 | — | — | WO | disclosed |
| WO-2012080449-A1 | AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS | JANSSEN R&D IRELAND (IE) | 2012-06-21 | — | — | WO | disclosed |
| WO-2011044157-A1 | HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | BIOGEN IDEC MA INC. (US) | 2011-04-14 | — | — | WO | disclosed |
| WO-2010042674-A1 | PYRROLONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-04-15 | — | — | WO | disclosed |
| US-7423128-B2 | Anti-properdin antibodies, and methods for making and using same | AMGEN FREMONT INC. (US) | 2008-09-09 | — | — | US | disclosed |